Top Markets
Coin of the day
HLS Therapeutics Inc. HLS Therapeutics Inc.

HLS Therapeutics Inc.

HLS
Hisse Senetlerindeki Sıralama #22602
HLS Therapeutics Inc. operates as a specialized pharmaceutical firm,... HLS Therapeutics Inc. operates as a specialized pharmaceutical firm, concentrating on the acquisition and commercialization of medicinal products, primarily within the niche central nervous system (CNS) and cardiovascular (CV) sectors. Its reach extends across Canada, the United States, and international markets. The company's core product lineup includes Clozaril, an atypical antipsychotic used in the treatment of schizophrenia; Vascepa, an icosapent ethyl capsule formulation; and PERSERIS, an injectable risperidone product for treating schizophrenia. Additionally, HLS offers MyCare psychiatry laboratory assays and MyCare Insite tests for point-of-care therapeutic drug-level monitoring. Furthermore, the company possesses U.S. marketing privileges for Absorica, a commercial-stage dermatology solution, and Canadian rights for Trinomia, a cardiovascular therapeutic. It also manages a portfolio of royalty interests from four distinct healthcare products. Founded in 2018, HLS Therapeutics Inc. is based in Etobicoke, Canada.
Hisse Fiyatı
$2.75
Son senkronizasyon: 2026-08-21
Piyasa Değeri
$86.08M
Değişim (1 gün)
-3.85%
Değişim (1 yıl)
-27.06%
Ülke
CA
Ticaret HLS Therapeutics Inc. (HLS)

Kategori

HLS Therapeutics Inc. (HLS) için hisse senedi fiyat geçmişi
Gün sonu en yüksek fiyat: $2.84 - 2026-08-01

Gün sonu en düşük fiyat: $8.95 - 2018-03-01
HLS Therapeutics Inc. için hisse fiyatı geçmişi: 2018 - 2026
Yıllık Hisse Fiyatı Performansı
Yıl Performans
2026 (TTM) -2.35%
2025 38.06%
2024 -5.73%
2023 -63.25%
2022 -36.71%
2021 -13.17%
2020 -7.23%
2019 30.14%
2018 0.00%
Benzer şirketler veya rakiplerin hisse fiyatı
Şirket Hisse fiyatı Değişim 1yıl% Ülke
$171.67 -
DE
$163.63 24.47%
DE
$37.61 20.44%
JP
$223.11 32.20%
CH
$20.99 11.67%
IN